Brief: Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026
17/12/2025 14:32
Dec 17 (Reuters) - Tenax Therapeutics Inc TENX.O: TENAX THERAPEUTICS INC - LEVEL TRIAL ON TRACK TO COMPLETE ENROLLMENT IN FIRST HALF OF 2026; TOPLINE DATA EXPECTED IN SECOND HALF OF 2026 Source text: ID:nGNX6cChdx Further company coverage: TENX.O ((Reuters.Briefs@thomsonreuters.com;))